Table of Contents Table of Contents
Previous Page  589 692 Next Page
Information
Show Menu
Previous Page 589 692 Next Page
Page Background

recruitment, and T-cell activation, including increased T

helper cell (Th) 1 and Th2 markers in rejecting tissues,

which was largely prevented by CsA treatment. These data

support the hypothesis that the MLR recapitulates the

complex interaction of innate and adaptive immune

systems with allogenic tissue. In addition, flow cytometry

of PBMCs exposed to allogenic cavernous tissues treated

with CsA had significantly decreased proliferation indices

compared with nontreated PBMCs exposed to allogenic

cavernous tissues (1.16 0.09 vs 6.48 0.37,

p

<

0.001)

(data not shown).

3.3.

Histological characterization of rejecting tissues

Given the decrease in nerve-mediated smooth muscle

contraction and relaxation measured by EFS myography,

we subsequently assessed penile tissue architecture via

histomorphology

( Fig. 4

a–4d). Histochemical evaluation

[(Fig._4)TD$FIG]

Fig. 4 – Representative histology of human cavernous tissue cultured for 48 h in control (media) and mixed lymphocyte reaction (MLR) conditions.

(a–d) Representative hematoxylin and eosin and (e–h) Masson’s trichrome staining of tissue groups demonstrating smooth muscle and connective tissue

content. (i–l) Giemsa stain of inflammatory cells with outlined high-power fields (m–p) demonstrating a qualitative increase in the presence of

inflammatory cells in the allograft MLR (Allo) compared with media, autologous MLR, and 1-

m

M cyclosporine A–treated Allo. (q–t) Terminal

deoxynucleotidyl transferase dUTP nick-end labeling stain demonstrating a qualitative increase in apoptotic nuclei in Allo tissues. Bar represents 100

m

M.

Allo = allograft mixed lymphocyte reaction; Auto = autologous mixed lymphocyte reaction; CsA = 1-

m

M cyclosporine A–treated allograft mixed lymphocyte

reaction; H&E = hematoxylin and eosin; TUNEL = terminal deoxynucleotidyl transferase dUTP nick-end labeling.

E U R O P E A N U R O L O G Y 7 1 ( 2 0 1 7 ) 5 8 4 – 5 9 3

589